Identification of a Panel of Candidate Epigenetic Biomarkers for Non-Small Cell Lung Cancer
张有为,王锐,宋海珠,黄桂春,易俊,郑芸,王靖华,陈龙邦
DOI: https://doi.org/10.3969/j.issn.1008-8199.2010.07.010
2010-01-01
Abstract:Objective 5′-CpG methylation of tumor suppressor genes (TSGs) is a universal epigenetic change in non-small cell lung cancer (NSCLC).This study aimed to identify a panel of candidate epigenetic biomarkers for NSCLC in the Chinese population.Methods We obtained 78 paired specimens of NSCLC and adjacent normal lung tissues,as well as plasma samples from 110 cases of stage I/II NSCLC and 50 cancer-free controls,and determined the methylation status of 20 lung cancer-related TSGs using methylation-specific polymerase chain reaction (MSP).Results Twelve of the genes,APC,CDH13,KLK10,DLEC1,RASSF1A,EFEMP1,SFRP1,RARβ,p16INK4A,RUNX3,hMLH1 and DAPK,exhibited a significantly higher frequency of methylation in NSCLC than in the normal tissues,especially the first 9 (P ≤ 0.001),while the other 8 genes,BRCA1,p14ARF,MGMT,NORE1A,FHIT,CMTM3,LSAMP and OPCML,showed low sensitivity or specificity of methylation in NSCLC.Furthermore,methylation of multiple genes was frequently seen in cancerous tissues,with the CpG island methylator phenotype (CIMP) positive in 65.38% (51/78) of NSCLC but only in 1.28% (1/78) of the adjacent normal tissue samples (P 0.001),and the CIMP positivity was correlated with the advanced stage (P = 0.007) and lymphatic metastasis (P = 0.031).The 9 TSGs identified in cancerous tissues showed a significantly higher frequency of tumor-specific hypermethylation in NSCLC plasma,and a 5-gene set (APC,RASSF1A,CDH13,KLK10 and DLEC1) achieved a sensitivity of 83.64% and a specificity of 74.0% for NSCLC detection.Conclusion CIMP positivity plays an important role in NSCLC initiation and progression;the combined detection of the 5 genes APC,RASSF1A,CDH13,KLK10 and DLEC1 can be used as an auxiliary tool for the diagnosis of NSCLC.